Display options
Share it on

Clin Ophthalmol. 2017 Aug 09;11:1461-1469. doi: 10.2147/OPTH.S142167. eCollection 2017.

Evaluation of the effect of corneal collagen cross-linking for keratoconus on the ocular higher-order aberrations.

Clinical ophthalmology (Auckland, N.Z.)

Ahmed Abdel-Karim El-Massry, Amgad Mostafa Dowidar, Tamer Hamdy Massoud, Baher Guirguis Daoud Tadros

Affiliations

  1. Department of Ophthalmology, Faculty of Medicine, Alexandria University, Alexandria Governorate, Egypt.

PMID: 28860694 PMCID: PMC5558591 DOI: 10.2147/OPTH.S142167

Abstract

BACKGROUND: Corneal collagen cross-linking (CXL) is the only treatment currently available to arrest the progression of keratoconus. The procedure consists of photopolymerization of stromal collagen fibers induced by combined action of a photosensitizing substance (riboflavin or vitamin B2) and ultraviolet-A light.

PURPOSE: To determine changes in the ocular higher-order aberrations (HOAs) after CXL and its correlation with changes in visual acuity.

DESIGN: Prospective interventional study.

SUBJECTS AND METHODS: This study was conducted on 30 eyes of 16 patients with progressive keratoconus documented between 2012 and 2014. Patients were treated with epithelium-off CXL and followed for a minimum of 6 months. The following ocular HOAs were measured and analyzed using I-Tracey Aberrometer: coma, trefoil, spherical aberration, astigmatism, and total HOAs.

RESULTS: There was statistically significant improvement in uncorrected visual acuity and best-corrected visual acuity between the preoperative and 6-month evaluations (

CONCLUSION: Total HOAs, total coma, and spherical aberrations decreased after CXL. Coma has a direct relationship with the improvement of visual function.

Keywords: collagen cross-linking; progressive keratoconus; ultraviolet irradiation; wavefront aberrations

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. Cont Lens Anterior Eye. 2005 Jun;28(2):57-66 - PubMed
  2. J Ophthalmol. 2015;2015:925414 - PubMed
  3. J Cataract Refract Surg. 2008 May;34(5):796-801 - PubMed
  4. Cont Lens Anterior Eye. 2010 Aug;33(4):157-66; quiz 205 - PubMed
  5. Optom Vis Sci. 1997 Nov;74(11):963-9 - PubMed
  6. J Cataract Refract Surg. 2012 Feb;38(2):292-302 - PubMed
  7. J Cataract Refract Surg. 2011 May;37(5):914-22 - PubMed
  8. J Refract Surg. 2007 Oct;23(8):774-81 - PubMed
  9. Cornea. 2015 Dec;34(12):e38-9 - PubMed
  10. J Ophthalmic Vis Res. 2011 Jul;6(3):155-9 - PubMed
  11. J Refract Surg. 2002 May-Jun;18(3):263-70 - PubMed
  12. Ophthalmology. 2009 Mar;116(3):369-78 - PubMed
  13. Cornea. 2016 Mar;35(3):417-28 - PubMed
  14. Am J Ophthalmol. 2003 May;135(5):620-7 - PubMed
  15. Am J Ophthalmol. 2005 Oct;140(4):607-11 - PubMed
  16. Eye (Lond). 2004 Apr;18(4):379-83 - PubMed
  17. J Cataract Refract Surg. 2006 May;32(5):837-45 - PubMed
  18. J Refract Surg. 2006 Jun;22(6):539-45 - PubMed
  19. J Cataract Refract Surg. 2015 Jan;41(1):41-6 - PubMed
  20. J Refract Surg. 2002 Sep-Oct;18(5):S556-62 - PubMed
  21. J Cataract Refract Surg. 2003 Aug;29(8):1487-95 - PubMed
  22. Am J Ophthalmol. 2009 Dec;148(6):844-51.e2 - PubMed
  23. J Refract Surg. 2004 Sep-Oct;20(5):S537-41 - PubMed
  24. J Refract Surg. 2000 Sep-Oct;16(5):S572-5 - PubMed
  25. Ophthalmology. 2002 Nov;109(11):1996-2003 - PubMed
  26. Surv Ophthalmol. 1984 Jan-Feb;28(4):293-322 - PubMed

Publication Types